{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:19:27Z","timestamp":1791505167767,"version":"4.3.4"},"reference-count":108,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["RCCFELCDF-May21\\\\100007"],"award-info":[{"award-number":["RCCFELCDF-May21\\\\100007"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","award":["G-002800"],"award-info":[{"award-number":["G-002800"]}],"id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","award":["G-002508"],"award-info":[{"award-number":["G-002508"]}],"id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015652","name":"Barts Charity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015652","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100024140","name":"ASH Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100024140","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009148","name":"Queen Mary University of London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009148","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019154","name":"Barts Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019154","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cancer"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.trecan.2025.10.002","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T17:50:12Z","timestamp":1763661012000},"page":"80-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Functional plasticity of RNA-binding proteins in cancer: both friend and foe"],"prefix":"10.1016","volume":"12","author":[{"given":"Lauren","family":"Harrison-Oakes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wisdom","family":"Igiogbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8328-0009","authenticated-orcid":false,"given":"Diu T.T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trecan.2025.10.002_bb0005","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1016\/j.molcel.2024.08.030","article-title":"Large-scale map of RNA-binding protein interactomes across the mRNA life cycle","volume":"84","author":"Street","year":"2024","journal-title":"Mol. Cell"},{"key":"10.1016\/j.trecan.2025.10.002_bb0010","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41590-017-0028-4","article-title":"RNA-binding proteins control gene expression and cell fate in the immune system","volume":"19","author":"Turner","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.trecan.2025.10.002_bb0015","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3389\/fnmol.2017.00420","article-title":"Silencing NUDT21 Attenuates the mesenchymal identity of glioblastoma cells via the NF-kappaB pathway","volume":"10","author":"Lou","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.trecan.2025.10.002_bb0020","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/nm.4416","article-title":"The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells","volume":"23","author":"Vu","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.trecan.2025.10.002_bb0025","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13059-021-02271-9","article-title":"ADAR1 is a new target of METTL3 and plays a pro-oncogenic role in glioblastoma by an editing-independent mechanism","volume":"22","author":"Tassinari","year":"2021","journal-title":"Genome Biol."},{"key":"10.1016\/j.trecan.2025.10.002_bb0030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1182\/blood.2020009676","article-title":"YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner","volume":"138","author":"Feng","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.trecan.2025.10.002_bb0035","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41556-024-01607-4","article-title":"Selective translational control by PABPC1 phase separation regulates blast crisis and therapy resistance in chronic myeloid leukaemia","volume":"27","author":"Sun","year":"2025","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.trecan.2025.10.002_bb0040","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.1038\/s41467-024-49874-x","article-title":"HuR controls glutaminase RNA metabolism","volume":"15","author":"Adamoski","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.10.002_bb0045","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ebiom.2018.11.007","article-title":"SRSF1 modulates PTPMT1 alternative splicing to regulate lung cancer cell radioresistance","volume":"38","author":"Sheng","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.trecan.2025.10.002_bb0050","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adl2171","article-title":"The tumor-intrinsic role of the m6A reader YTHDF2 in regulating immune evasion","volume":"9","author":"Xiao","year":"2024","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.trecan.2025.10.002_bb0055","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.7150\/thno.71872","article-title":"RNA N6-methyladenosine reader YTHDC1 is essential for TGF-beta-mediated metastasis of triple negative breast cancer","volume":"12","author":"Tan","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.trecan.2025.10.002_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108772","article-title":"RNA binding protein PUM2 promotes the stemness of breast cancer cells via competitively binding to neuropilin-1 (NRP-1) mRNA with miR-376a","volume":"114","author":"Zhang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.trecan.2025.10.002_bb0065","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","article-title":"Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia","volume":"593","author":"Yankova","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2025.10.002_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113307","article-title":"Pharmacological depletion of RNA splicing factor RBM39 by indisulam synergizes with PARP inhibitors in high-grade serous ovarian carcinoma","volume":"42","author":"Xu","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.trecan.2025.10.002_bb0075","article-title":"Treatment of acute myeloid leukemia models by targeting a cell surface RNA-binding protein","author":"George","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.trecan.2025.10.002_bb0080","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3390\/cancers14061590","article-title":"Immune landscape and an RBM38-associated immune prognostic model with laboratory verification in malignant melanoma","volume":"14","author":"Liu","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.trecan.2025.10.002_bb0085","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41586-023-05820-3","article-title":"RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer","volume":"617","author":"Jbara","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2025.10.002_bb0090","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13046-021-01978-8","article-title":"Splicing factor SRSF1 promotes breast cancer progression via oncogenic splice switching of PTPMT1","volume":"40","author":"Du","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.trecan.2025.10.002_bb0095","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.celrep.2011.12.001","article-title":"Oncogenic splicing factor SRSF1 is a critical transcriptional target of MYC","volume":"1","author":"Das","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.trecan.2025.10.002_bb0100","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.cellsig.2014.01.022","article-title":"Mutual inhibition between YAP and SRSF1 maintains long non-coding RNA, Malat1-induced tumourigenesis in liver cancer","volume":"26","author":"Wang","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.trecan.2025.10.002_bb0105","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1038\/s41467-020-15733-8","article-title":"MBNL1 regulates essential alternative RNA splicing patterns in MLL-rearranged leukemia","volume":"11","author":"Itskovich","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.10.002_bb0110","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1101\/gad.270645.115","article-title":"Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts","volume":"30","author":"Fish","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.trecan.2025.10.002_bb0115","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1158\/0008-5472.CAN-20-1233","article-title":"The alternative splicing factor, MBNL1, inhibits glioblastoma tumor initiation and progression by reducing hypoxia-induced stemness","volume":"80","author":"Voss","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2025.10.002_bb0120","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s41419-022-05219-4","article-title":"The MBNL1\/circNTRK2\/PAX5 pathway regulates aerobic glycolysis in glioblastoma cells by encoding a novel protein NTRK2-243aa","volume":"13","author":"Zhao","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.trecan.2025.10.002_bb0125","first-page":"955","article-title":"Muscleblind-like 1 destabilizes Snail mRNA and suppresses the metastasis of colorectal cancer cells via the Snail\/E-cadherin axis","volume":"54","author":"Tang","year":"2019","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.trecan.2025.10.002_bb0130","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/carcin\/bgv066","article-title":"The polymorphic terminal-loop of pre-miR-1307 binding with MBNL1 contributes to colorectal carcinogenesis via interference with Dicer1 recruitment","volume":"36","author":"Tang","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.trecan.2025.10.002_bb0135","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.stemcr.2022.11.016","article-title":"CFIm-mediated alternative polyadenylation safeguards the development of mammalian pre-implantation embryos","volume":"18","author":"Li","year":"2023","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.trecan.2025.10.002_bb0140","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abh0562","article-title":"Alternative polyadenylation is a determinant of oncogenic Ras function","volume":"7","author":"Subramanian","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.trecan.2025.10.002_bb0145","doi-asserted-by":"crossref","first-page":"7156","DOI":"10.7150\/thno.36030","article-title":"NUDT21 inhibits bladder cancer progression through ANXA2 and LIMK2 by alternative polyadenylation","volume":"9","author":"Xiong","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.trecan.2025.10.002_bb0150","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1038\/s41388-018-0280-6","article-title":"NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression","volume":"37","author":"Tan","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.trecan.2025.10.002_bb0155","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1038\/s41388-021-01693-w","article-title":"Downregulation of NUDT21 contributes to cervical cancer progression through alternative polyadenylation","volume":"40","author":"Xing","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.trecan.2025.10.002_bb0160","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nature13261","article-title":"CFIm25 links alternative polyadenylation to glioblastoma tumour suppression","volume":"510","author":"Masamha","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2025.10.002_bb0165","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1038\/s41586-022-05459-6","article-title":"Author Correction: CFIm25 links alternative polyadenylation to glioblastoma tumour suppression","volume":"612","author":"Masamha","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2025.10.002_bb0170","article-title":"Nudt21-mediated alternative polyadenylation of MZT1 3\u2032 UTR contributes to pancreatic cancer progression","volume":"27","author":"Zhou","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.trecan.2025.10.002_bb0175","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/s41388-019-1030-0","article-title":"NUDT21 regulates circRNA cyclization and ceRNA crosstalk in hepatocellular carcinoma","volume":"39","author":"Li","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.trecan.2025.10.002_bb0180","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.2147\/CMAR.S173496","article-title":"Knockdown of NUDT21 inhibits proliferation and promotes apoptosis of human K562 leukemia cells through ERK pathway","volume":"10","author":"Zhang","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.trecan.2025.10.002_bb0185","article-title":"NUDT21 promotes tumor growth and metastasis through modulating SGPP2 in human gastric cancer","volume":"11","author":"Zhu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.trecan.2025.10.002_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1240063","article-title":"Corrigendum: NUDT21 promotes tumor growth and metastasis through modulating SGPP2 in human gastric cancer","volume":"13","author":"Zhu","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.trecan.2025.10.002_bb0195","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3389\/fonc.2020.00115","article-title":"METTL3 promotes the progression of gastric cancer via targeting the MYC pathway","volume":"10","author":"Yang","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.trecan.2025.10.002_bb0200","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41419-023-05715-1","article-title":"METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation","volume":"14","author":"Lin","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.trecan.2025.10.002_bb0205","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/s41419-023-06287-w","article-title":"METTL3 promotes colorectal cancer progression through activating JAK1\/STAT3 signaling pathway","volume":"14","author":"Sun","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.trecan.2025.10.002_bb0210","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/s41556-022-00968-y","article-title":"METTL3 preferentially enhances non-m6A translation of epigenetic factors and promotes tumourigenesis","volume":"24","author":"Wei","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.trecan.2025.10.002_bb0215","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s41388-023-02602-z","article-title":"METTL3 regulates breast cancer-associated alternative splicing switches","volume":"42","author":"Achour","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.trecan.2025.10.002_bb0220","article-title":"Dissecting the effects of METTL3 on alternative splicing in prostate cancer","volume":"13","author":"Wang","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.trecan.2025.10.002_bb0225","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.ymthe.2021.01.019","article-title":"METTL3 restrains papillary thyroid cancer progression via m6A\/c-Rel\/IL-8-mediated neutrophil infiltration","volume":"29","author":"He","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.trecan.2025.10.002_bb0230","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/j.molcel.2022.04.010","article-title":"The Mettl3 epitranscriptomic writer amplifies p53 stress responses","volume":"82","author":"Raj","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.trecan.2025.10.002_bb0235","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3390\/genes13040669","article-title":"An alternatively spliced variant of METTL3 mediates tumor suppression in hepatocellular carcinoma","volume":"13","author":"Xu","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.trecan.2025.10.002_bb0240","first-page":"474","article-title":"Targeting ADAR1 with a small molecule for the treatment of prostate cancer","volume":"6","author":"Wang","year":"2025","journal-title":"Nat. Can."},{"key":"10.1016\/j.trecan.2025.10.002_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106864","article-title":"ADAR1-mediated RNA editing promotes B cell lymphomagenesis","volume":"26","author":"Pecori","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.trecan.2025.10.002_bb0250","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1182\/blood-2018-02-832576","article-title":"Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis","volume":"132","author":"Teoh","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.trecan.2025.10.002_bb0255","first-page":"148","article-title":"The aberrant expression of ADAR1 promotes resistance to BET inhibitors in pancreatic cancer by stabilizing c-Myc","volume":"10","author":"Sun","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.trecan.2025.10.002_bb0260","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41467-020-14621-5","article-title":"Cis- and trans-regulations of pre-mRNA splicing by RNA editing enzymes influence cancer development","volume":"11","author":"Tang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.10.002_bb0265","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1038\/s41467-018-06405-9","article-title":"RNA editing derived epitopes function as cancer antigens to elicit immune responses","volume":"9","author":"Zhang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.10.002_bb0270","doi-asserted-by":"crossref","first-page":"10715","DOI":"10.1038\/ncomms10715","article-title":"The mRNA-edited form of GABRA3 suppresses GABRA3-mediated Akt activation and breast cancer metastasis","volume":"7","author":"Gumireddy","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.10.002_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118716","article-title":"ADAR1 Transcriptome editing promotes breast cancer progression through the regulation of cell cycle and DNA damage response","volume":"1867","author":"Sagredo","year":"2020","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"key":"10.1016\/j.trecan.2025.10.002_bb0280","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cell.2024.11.007","article-title":"YTHDF2 promotes ATP synthesis and immune evasion in B cell malignancies","volume":"188","author":"Chen","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2025.10.002_bb0285","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/s41467-020-15403-9","article-title":"An oncopeptide regulates m6A recognition by the m6A reader IGF2BP1 and tumorigenesis","volume":"11","author":"Zhu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.10.002_bb0290","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1016\/j.molcel.2021.06.014","article-title":"Inhibition of YTHDF2 triggers proteotoxic cell death in MYC-driven breast cancer","volume":"81","author":"Einstein","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.trecan.2025.10.002_bb0295","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12575-023-00195-1","article-title":"YTHDF2 exerts tumor-suppressor roles in gastric cancer via up-regulating PPP2CA independently of m6A modification","volume":"25","author":"Zhou","year":"2023","journal-title":"Biol. Proced. Online"},{"key":"10.1016\/j.trecan.2025.10.002_bb0300","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.canlet.2018.11.006","article-title":"YTHDF2 suppresses cell proliferation and growth via destabilizing the EGFR mRNA in hepatocellular carcinoma","volume":"442","author":"Zhong","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.trecan.2025.10.002_bb0305","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1038\/s41388-020-1303-7","article-title":"YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation","volume":"39","author":"Zhang","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.trecan.2025.10.002_bb0310","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1080\/15384101.2017.1380125","article-title":"YTH domain family 2 orchestrates epithelial\u2013mesenchymal transition\/proliferation dichotomy in pancreatic cancer cells","volume":"16","author":"Chen","year":"2017","journal-title":"Cell Cycle"},{"key":"10.1016\/j.trecan.2025.10.002_bb0315","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41419-022-05544-8","article-title":"A potassium-chloride co-transporter promotes tumor progression and castration resistance of prostate cancer through m6A reader YTHDC1","volume":"14","author":"Yuan","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.trecan.2025.10.002_bb0320","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.ccell.2021.04.017","article-title":"N6-methyladenosine on mRNA facilitates a phase-separated nuclear body that suppresses myeloid leukemic differentiation","volume":"39","author":"Cheng","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2025.10.002_bb0325","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7494354","article-title":"YTHDC1 promotes stemness maintenance and malignant progression in head and neck squamous cell carcinoma","volume":"2022","author":"Weng","year":"2022","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.trecan.2025.10.002_bb0330","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1038\/s41418-021-00804-0","article-title":"YTHDC1-mediated augmentation of miR-30d in repressing pancreatic tumorigenesis via attenuation of RUNX1-induced transcriptional activation of Warburg effect","volume":"28","author":"Hou","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.trecan.2025.10.002_bb0335","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1038\/s41418-023-01234-w","article-title":"YTHDC1 as a tumor progression suppressor through modulating FSP1-dependent ferroptosis suppression in lung cancer","volume":"30","author":"Yuan","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.trecan.2025.10.002_bb0340","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13404","article-title":"YTHDC1 positively regulates PTEN expression and plays a critical role in cisplatin resistance of bladder cancer","volume":"56","author":"Su","year":"2023","journal-title":"Cell Prolif."},{"key":"10.1016\/j.trecan.2025.10.002_bb0345","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1158\/1541-7786.MCR-16-0275-T","article-title":"LIN28B activation by PRL-3 promotes Leukemogenesis and a stem cell-like transcriptional program in AML","volume":"15","author":"Zhou","year":"2017","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.trecan.2025.10.002_bb0350","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13045-017-0507-y","article-title":"Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia","volume":"10","author":"Zhou","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.trecan.2025.10.002_bb0355","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41419-024-06564-2","article-title":"LIN28B induced PCAT5 promotes endometrial cancer progression and glycolysis via IGF2BP3 deubiquitination","volume":"15","author":"Wang","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.trecan.2025.10.002_bb0360","doi-asserted-by":"crossref","DOI":"10.1172\/JCI165734","article-title":"Liver cancer initiation requires translational activation by an oncofetal regulon involving LIN28 proteins","volume":"134","author":"Hsieh","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.trecan.2025.10.002_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112099","article-title":"A fetal tumor suppressor axis abrogates MLL-fusion-driven acute myeloid leukemia","volume":"42","author":"Eldeeb","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.trecan.2025.10.002_bb0370","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1038\/s41388-022-02326-6","article-title":"Reduced miR-371b-5p expression drives tumor progression via CSDE1\/RAC1 regulation in triple-negative breast cancer","volume":"41","author":"Kim","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.trecan.2025.10.002_bb0375","doi-asserted-by":"crossref","first-page":"143","DOI":"10.24920\/11815","article-title":"RNA-binding protein UNR promotes glioma cell migration and regulates the expression of ribosomal protein L9","volume":"33","author":"Tian","year":"2018","journal-title":"Chin. Med. Sci. J."},{"key":"10.1016\/j.trecan.2025.10.002_bb0380","first-page":"963","article-title":"miR-132 and miR-212 cluster function as a tumor suppressor in thyroid cancer cells by CSDE1 mediated post-transcriptional program","volume":"11","author":"Chen","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.trecan.2025.10.002_bb0385","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3390\/jcm8040560","article-title":"UNR\/CSDE1 expression is critical to maintain invasive phenotype of colorectal cancer through regulation of c-MYC and epithelial-to-mesenchymal transition","volume":"8","author":"Martinez-Useros","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.trecan.2025.10.002_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110211","article-title":"Coordinated post-transcriptional control of oncogene-induced senescence by UNR\/CSDE1","volume":"38","author":"Avolio","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.trecan.2025.10.002_bb0395","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive molecular characterization of pheochromocytoma and paraganglioma","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2025.10.002_bb0400","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210151","article-title":"E3 ligase MKRN3 is a tumor suppressor regulating PABPC1 ubiquitination in non-small cell lung cancer","volume":"218","author":"Li","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.trecan.2025.10.002_bb0405","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.canlet.2015.07.010","article-title":"PABPC1 interacts with AGO2 and is responsible for the microRNA mediated gene silencing in high grade hepatocellular carcinoma","volume":"367","author":"Zhang","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.trecan.2025.10.002_bb0410","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/s41388-024-02971-z","article-title":"LncRNA PRBC induces autophagy to promote breast cancer progression through modulating PABPC1-mediated mRNA stabilization","volume":"43","author":"Liang","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.trecan.2025.10.002_bb0415","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41419-020-2267-9","article-title":"PABPC1-induced stabilization of BDNF-AS inhibits malignant progression of glioblastoma cells through STAU1-mediated decay","volume":"11","author":"Su","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.trecan.2025.10.002_bb0420","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1038\/sj.onc.1210127","article-title":"Isoforms of Wilms\u2019 tumor suppressor gene (WT1) have distinct effects on mammary epithelial cells","volume":"26","author":"Burwell","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.trecan.2025.10.002_bb0425","doi-asserted-by":"crossref","first-page":"45255","DOI":"10.1038\/srep45255","article-title":"WT1 expression in breast cancer disrupts the epithelial\/mesenchymal balance of tumour cells and correlates with the metabolic response to docetaxel","volume":"7","author":"Artibani","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.trecan.2025.10.002_bb0430","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12943-017-0724-6","article-title":"SUMO1 modification of KHSRP regulates tumorigenesis by preventing the TL-G-Rich miRNA biogenesis","volume":"16","author":"Yuan","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.trecan.2025.10.002_bb0435","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1101\/gad.221739.113","article-title":"Glycogen synthase kinase 3 promotes p53 mRNA translation via phosphorylation of RNPC1","volume":"27","author":"Zhang","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.trecan.2025.10.002_bb0440","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.molcel.2008.03.013","article-title":"The splicing factor SF2\/ASF regulates translation initiation by enhancing phosphorylation of 4E-BP1","volume":"30","author":"Michlewski","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.trecan.2025.10.002_bb0445","doi-asserted-by":"crossref","first-page":"8444","DOI":"10.1038\/s41467-023-44126-w","article-title":"RBFOX2 deregulation promotes pancreatic cancer progression and metastasis through alternative splicing","volume":"14","author":"Maurin","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.10.002_bb0450","first-page":"1","article-title":"Rbfox2 dissociation from stress granules suppresses cancer progression","volume":"51","author":"Choi","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.trecan.2025.10.002_bb0455","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/cas.16420","article-title":"PHAX enhanced LIN28B-mediated PBX3 mRNA stability to promote esophageal cancer development","volume":"116","author":"Peng","year":"2024","journal-title":"Cancer Sci."},{"key":"10.1016\/j.trecan.2025.10.002_bb0460","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3389\/fonc.2020.00613","article-title":"Silencing SCAMP1-TV2 inhibited the malignant biological behaviors of breast cancer cells by interaction with PUM2 to facilitate INSM1 mRNA degradation","volume":"10","author":"Tao","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.trecan.2025.10.002_bb0465","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/s41388-020-01638-9","article-title":"A novel hypoxic long noncoding RNA KB-1980E6. 3 maintains breast cancer stem cell stemness via interacting with IGF2BP1 to facilitate c-Myc mRNA stability","volume":"40","author":"Zhu","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.trecan.2025.10.002_bb0470","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1091\/mbc.E14-11-1500","article-title":"Competition between RNA-binding proteins CELF1 and HuR modulates MYC translation and intestinal epithelium renewal","volume":"26","author":"Liu","year":"2015","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.trecan.2025.10.002_bb0475","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1128\/MCB.26.8.3295-3307.2006","article-title":"Translational control of cytochrome c by RNA-binding proteins TIA-1 and HuR","volume":"26","author":"Kawai","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.trecan.2025.10.002_bb0480","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/nsmb.1874","article-title":"Antagonistic role of hnRNP A1 and KSRP in the regulation of let-7a biogenesis","volume":"17","author":"Michlewski","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.trecan.2025.10.002_bb0485","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1038\/s41467-020-15814-8","article-title":"HyperTRIBE uncovers increased MUSASHI-2 RNA binding activity and differential regulation in leukemic stem cells","volume":"11","author":"Nguyen","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.10.002_bb0490","article-title":"Pathogenetic significance of YBX1 expression in acute myeloid leukemia relapse","volume":"70","author":"Gouda","year":"2022","journal-title":"Curr. Res. Transl. Med."},{"key":"10.1016\/j.trecan.2025.10.002_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.07.001","article-title":"Cancer the \u2018RBP\u2019eutics \u2013 RNA-binding proteins as therapeutic targets for cancer","volume":"203","author":"Mohibi","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.trecan.2025.10.002_bb0500","first-page":"741","article-title":"Transcriptional control of CBX5 by the RNA binding proteins RBMX and RBMXL1 maintains chromatin state in myeloid leukemia","volume":"2","author":"Prieto","year":"2021","journal-title":"Nat. Can."},{"key":"10.1016\/j.trecan.2025.10.002_bb2005","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41419-023-06413-8","article-title":"The multifaceted role of Fragile X-Related Protein 1 (FXR1) in cellular processes: an updated review on cancer and clinical applications","volume":"15","author":"Khan","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.trecan.2025.10.002_bb0505","doi-asserted-by":"crossref","first-page":"14657","DOI":"10.1038\/s41598-021-94128-1","article-title":"A hypoxia risk signature for the tumor immune microenvironment evaluation and prognosis prediction in acute myeloid leukemia","volume":"11","author":"Jiang","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.trecan.2025.10.002_bb0510","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/ncb3110","article-title":"Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis","volume":"17","author":"Shoshan","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.trecan.2025.10.002_bb0515","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41467-018-02851-7","article-title":"A-to-I miR-378a-3p editing can prevent melanoma progression via regulation of PARVA expression","volume":"9","author":"Velazquez-Torres","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.10.002_bb0520","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.197","article-title":"CPEB1, a histone-modified hypomethylated gene, is regulated by miR-101 and involved in cell senescence in glioma","volume":"4","author":"Xiaoping","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.trecan.2025.10.002_bb0525","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.omto.2021.03.007","article-title":"miR-301 regulates the SIRT1\/SOX2 pathway via CPEB1 in the breast cancer progression","volume":"22","author":"Jia","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.trecan.2025.10.002_bb0530","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41419-023-05862-5","article-title":"The HOXD9-mediated PAXIP1-AS1 regulates gastric cancer progression through PABPC1\/PAK1 modulation","volume":"14","author":"Li","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.trecan.2025.10.002_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107753","article-title":"Enhancer-driven lncRNA BDNF-AS induces endocrine resistance and malignant progression of breast cancer through the RNH1\/TRIM21\/mTOR cascade","volume":"31","author":"Lin","year":"2020","journal-title":"Cell Rep."}],"container-title":["Trends in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803325002535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803325002535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:55:11Z","timestamp":1778882111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405803325002535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":108,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2405803325002535"],"URL":"https:\/\/doi.org\/10.1016\/j.trecan.2025.10.002","relation":{},"ISSN":["2405-8033"],"issn-type":[{"value":"2405-8033","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional plasticity of RNA-binding proteins in cancer: both friend and foe","name":"articletitle","label":"Article Title"},{"value":"Trends in Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trecan.2025.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}